Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions

[1] Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33

[2] Miller KD(2016)See-and-treat for high-grade cytology: do young women have different rates of high-grade histology? J Lower Genital Tract Dis 20 243-246

[3] Fuchs HE(2008)Natural history and epidemiology of HPV infection and cervical cancer Gynecol Oncol 110 S4-S7

[4] Jemal A(2020)Serum lncRNAs (CCAT2, LINC01133, LINC00511) with squamous cell carcinoma antigen panel as novel non-invasive biomarkers for detection of cervical squamous carcinoma Cancer Manag Res 12 9495-9502

[5] Smith HJ(2000)Endocervical curettage in evaluating abnormal cervical cytology J Reprod Med 45 285-292

[6] Leath CA(2020)2019 ASCCP risk-based management consensus guidelines for abnormal cervical Cancer screening tests and Cancer precursors J Lower Genital Tract Dis 24 102-131

[7] Huh WK(1985)Colposcopy for postmenopausal women Gynecol Oncol 20 62-70

[8] Erickson BK(2017)A retrospective analysis of the utility of endocervical curettage in screening population Oncotarget 8 50141-50147

[9] Castellsagué X(2014)Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens Am J Clin Pathol 141 342-347

[10] Wang W-J(2008)To ECC or not to ECC: the question remains Obstet Gynecol Clin N Am 35 583-597

[1] Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33

[2] Miller KD(2016)See-and-treat for high-grade cytology: do young women have different rates of high-grade histology? J Lower Genital Tract Dis 20 243-246

[3] Fuchs HE(2008)Natural history and epidemiology of HPV infection and cervical cancer Gynecol Oncol 110 S4-S7

[4] Jemal A(2020)Serum lncRNAs (CCAT2, LINC01133, LINC00511) with squamous cell carcinoma antigen panel as novel non-invasive biomarkers for detection of cervical squamous carcinoma Cancer Manag Res 12 9495-9502

[5] Smith HJ(2000)Endocervical curettage in evaluating abnormal cervical cytology J Reprod Med 45 285-292

[6] Leath CA(2020)2019 ASCCP risk-based management consensus guidelines for abnormal cervical Cancer screening tests and Cancer precursors J Lower Genital Tract Dis 24 102-131

[7] Huh WK(1985)Colposcopy for postmenopausal women Gynecol Oncol 20 62-70

[8] Erickson BK(2017)A retrospective analysis of the utility of endocervical curettage in screening population Oncotarget 8 50141-50147

[9] Castellsagué X(2014)Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens Am J Clin Pathol 141 342-347

[10] Wang W-J(2008)To ECC or not to ECC: the question remains Obstet Gynecol Clin N Am 35 583-597